It is a trading private limited company based in Delhi, Delhi, India, established in 2011.
2011 | Delhi, Delhi, India | ActivePrimecure Medicines Private Limited, a active private limited company, was established on 18 October 2011 in Delhi, Delhi, India. Engaging in other wholesale within the trade sector, it holds CIN: U24232DL2011PTC226376. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Mahesh Anand (Director), Sharat Latta (Director), Vibha Yadav Latta (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No T4, Plot No. 9, Sharda Chamber Blk-D Lsc, Parshant Vihar, Rohini, Delhi, Delhi, 110085.
U24232DL2011PTC226376
226376
18 October 2011
₹0.50 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Primecure Medicines Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mahesh Anand | Director | 18 Oct 2011 | Current |
| Sharat Latta | Director | 18 Oct 2011 | Current |
| Vibha Yadav Latta | Director | 18 Oct 2011 | Current |
| Veena Anand | Director | 18 Oct 2011 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Primecure Medicines Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Primecure Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Primecure Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Primecure Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Primecure Medicines's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Primecure Medicines Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Primecure Medicines Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Mahesh Anand was appointed as a Director was appointed as a Director on 18 Oct 2011 & has been associated with this company since 14 years 1 month . was recorded as a recent event.
Progress on Sharat Latta was appointed as a Director was appointed as a Director on 18 Oct 2011 & has been associated with this company since 14 years 1 month . was documented.
The activity Vibha Yadav Latta was appointed as a Director was appointed as a Director on 18 Oct 2011 & has been associated with this company since 14 years 1 month . was completed.
Veena Anand was appointed as a Director was appointed as a Director on 18 Oct 2011 & has been associated with this company since 14 years 1 month . was recorded as a recent event.
The CIN of Primecure Medicines Private Limited is U24232DL2011PTC226376.
Primecure Medicines Private Limited is headquartered at Office No T4, Plot No. 9, Sharda Chamber Blk-D Lsc, Parshant Vihar, Rohini, Delhi, Delhi, 110085.
Primecure Medicines Private Limited was incorporated on 18 October 2011.
The current directors of Primecure Medicines Private Limited are
The primary industry of Primecure Medicines Private Limited is Trade.
Primecure Medicines Private Limited is unlisted.
The authorized capital of Primecure Medicines Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Primecure Medicines Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX